Healthcare -
Biotechnology - NASDAQ - US
$ 21.4
3.68 %
$ 1.9 B
Market Cap
-5.26
P/E
TVTX - SHORT-TERM DEBT
Short-term Debt TVTX - Travere Therapeutics, Inc.
74.1 M
LAST VALUE
189.06%
2 YEAR CAGR
0.00%
5 YEAR CAGR
6.23%
10 YEAR CAGR